Tag: Cancer: Leukemia

Only 14 percent of hospitals that referred patients with acute promyelocytic leukemia had ATRA readily available

Vincristine and dexamethasone pulses might be eliminated during second year of treatment for children with low-risk disease

Seventy-five percent of patients achieved a best response of bone marrow-undetectable measurable residual disease remission

Survival improved across calendar periods for all age groups except for patients aged ≥70 years

Second study shows lower neutralizing antibody titers against SARS-CoV-2 after the first dose among elderly patients with multiple myeloma

Low-quality evidence suggests type/dose of steroid not linked to adverse psychological reactions, possibly associated with sleep problems

Risk particularly high for acute myeloid leukemia before age 5 years

Bluebird Bio says it has not found evidence that its gene therapy caused the sickle cell patient's leukemia

Prospective sequencing of samples provided new genetic information for 24.8 percent of patients, which changed risk category for 16.2 percent

Increased incidence of IKZF1 deletion and IGH-CRLF2 translocation seen in Hispanic/Latino children with B-ALL